(Q43891811)

English

CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation

scientific article published in February 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

immunosuppression

1 reference

based on heuristic

inferred from title

author name string

R Arranz

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

E Conde

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

F Rodriguez-Salvanés

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

F J Pajuelo

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

R Cabrera

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M A Sanz

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Petit

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Bueno

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Maldonado

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Odriozola

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J G Conde

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S Brunet

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

E Carreras

13

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A Iriondo

14

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J M Fernández-Rañada

15

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P Marín

16

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Subcomité de Aplasia Medular del Grupo Español de Trasplante Hemopoyético

17

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

205-211

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

21 January 2018

Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

21 January 2018

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

21 January 2018

Current status of allogeneic bone marrow transplantation in acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

21 January 2018

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival following bone marrow transplantation for aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

7 January 2021

based on heuristic

inferred from DOI database lookup

Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703349

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703349

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43891811&oldid=2206317466"